DOA
INVA icon

D'Orazio & Associates’s Innoviva INVA Stock Holding History

D'Orazio & Associates’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-70
Closed -$1K – 388
2021
Q3 		$1K Buy
+70
New +$1.05K ﹤0.01% 731
2019
Q2 		– Sell
-500
Closed -$7K – 349
2019
Q1 		$7K Buy
+500
New +$8.1K ﹤0.01% 259

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

D'Orazio & Associates's INVA Position: Q4 2021 in Review

D'Orazio & Associates sold out of Innoviva (INVA) in Q4 2021, closing a stake of 70 shares — an estimated $1K sold.

D'Orazio & Associates first reported a position in INVA in Q1 2019 and held it in 2 quarters. The position peaked at $7K in Q1 2019. 218 funds tracked by Wall St. Rank hold INVA as of Q4 2021.

  • D'Orazio & Associates reported no remaining Innoviva position as of Q4 2021 after selling out during the quarter.
  • D'Orazio & Associates sold 70 Innoviva shares in Q4 2021, an estimated $1K.
  • D'Orazio & Associates first reported a position in Innoviva in Q1 2019 and held it in 2 quarters.
  • D'Orazio & Associates's Innoviva position peaked at $7K in Q1 2019.
  • 218 funds tracked by Wall St. Rank held Innoviva as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.